No photo of R. Ruijter

R. Ruijter

20022019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

  • 9 Article
  • 1 Meeting Abstract
Open Access

A phase 1/2 study of intermittent, high dose sunitinib in patients with advanced solid tumors.

Rovithi, M., Labots, M., Richard, Honeywell, Ten Tije, A. J., Ruijter, R., Skardhamar, M., Peters, G. J., Voortman, J. & Verheul, H. M. W., 20 May 2017, In : Journal of Clinical Oncology. 35

Research output: Contribution to journalMeeting AbstractAcademic

38 Downloads (Pure)

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours

Kaye, S., Aamdal, S., Jones, R., Freyer, G., Pujade-Lauraine, E., de Vries, E. G. E., Barriuso, J., Sandhu, S., Tan, D. S. W., Hartog, V., Kuenen, B., Ruijter, R., Kristensen, G. B., Nyakas, M., Barrett, S., Burke, W., Pietersma, D., Stuart, M., Emeribe, U. & Boven, E., 2012, In : British Journal of Cancer. 106, 11, p. 1728-1734

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File